4.6 Article

Phylogeographical Landscape of Citrobacter portucalensis Carrying Clinically Relevant Resistomes

Journal

MICROBIOLOGY SPECTRUM
Volume 10, Issue 2, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/spectrum.01506-21

Keywords

Enterobacterales; emerging pathogens; multidrug-resistant; international clade; critical priority; One Health; genomic surveillance

Categories

Funding

  1. Bill & Melinda Gates Foundation [OPP1193112]
  2. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2020/08224-9, 2019/15578-4, 2015/13527-2]
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [443819/2018-1, 314336/2021-4, 433128/20186]
  4. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
  5. Agency for Research and Development (ANID) Scholarship Program Doctorado Becas Chile [2020-72210089]
  6. CNPq [314336/2021-4]
  7. Bill and Melinda Gates Foundation [OPP1193112] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This study in Brazil assessed critical priority pathogens circulating at the human-animal-environment interface and identified multidrug-resistant Citrobacter portucalensis in green sea turtles. The genomic analysis revealed the dissemination of different arrays of clinically relevant genes, making C. portucalensis a global priority pathogen.
During a surveillance study conducted to assess the occurrence and genomic landscape of critical priority pathogens circulating at the human-animal-environment interface in Brazil, as part of the Grand Challenges Explorations-New Approaches to Characterize the Global Burden of Antimicrobial Resistance program, two multidrug-resistant (MDR) Citrobacter portucalensis carrying bla(CTX-M-15) extended-spectrum beta-lactamase (ESBL) genes, isolated from green sea turtles, were characterized. Genomic and phylogeographical analysis of C. portucalensis genomes available in public databases revealed the intercontinental dissemination of clades carrying different arrays of clinically relevant genes conferring resistance to carbapenems, broad-spectrum cephalosporins, cephamycins, aminoglycosides and fluoroquinolones, disinfectants, and heavy metals. Our observations suggest that C. portucalensis could be emerging as critical priority bacteria of both public and One Health importance worldwide. IMPORTANCE The global spread of antibiotic-resistant priority pathogens beyond the hospital setting is a critical issue within a One Health context that integrates the human-animal-environment interfaces. On the other hand, next-generation sequencing technologies along with user-friendly and high-quality bioinformatics tools have improved the identification of bacterial species, and bacterial resistance surveillance. The novel Citrobacter portucalensis species was proposed in 2017 after taxonomic reclassification and definition of the strain A60(T) isolated in 2008. Here, we presented genomic data showing the occurrence of multidrug-resistant C. portucalensis isolates carrying bla(CTX-M-15) ESBL genes in South America. Additionally, we observed the intercontinental dissemination of clades harboring a broad resistome to clinically relevant antibiotics. Therefore, these findings highlight that C. portucalensis is a global MDR bacteria that carries intrinsic bla(CMY)- and qnrB-type genes and has become a critical priority pathogen due to the acquisition of clinically relevant resistance determinants, such as ESBL and carbapenemase-encoding genes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available